000 | 01231 a2200337 4500 | ||
---|---|---|---|
005 | 20250517164515.0 | ||
264 | 0 | _c20180124 | |
008 | 201801s 0 0 eng d | ||
022 | _a2405-8025 | ||
024 | 7 |
_a10.1016/j.trecan.2016.07.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCory, Suzanne | |
245 | 0 | 0 |
_aTargeting BCL-2-like Proteins to Kill Cancer Cells. _h[electronic resource] |
260 |
_bTrends in cancer _c08 2016 |
||
300 |
_a443-460 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAniline Compounds _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aBridged Bicyclo Compounds, Heterocyclic _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
700 | 1 | _aRoberts, Andrew W | |
700 | 1 | _aColman, Peter M | |
700 | 1 | _aAdams, Jerry M | |
773 | 0 |
_tTrends in cancer _gvol. 2 _gno. 8 _gp. 443-460 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.trecan.2016.07.001 _zAvailable from publisher's website |
999 |
_c27400409 _d27400409 |